Clinical Trial Update: A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease [NA]

View source ↗

Summary

Clinical trial update for a randomized study evaluating the Enhancor System, a pulmonary artery denervation device, in patients with combined pre- and post-capi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Heart Failure with Mid-range Ejection Fraction
• Heart Failure with Preserved Ejection Fraction
• Heart Failure with Reduced Ejection Fraction
• Hypertension
• Pulmonary Hypertension
• Vascular Diseases

Drugs mentioned

• Enhancor System

Snippet

Sponsor: Pulnovo Medical, Inc. | Conditions: Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction | NA | Status: NOT_YET_RECRUITING